N K Wenger

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi request reprint Menopausal hormone therapy: is there evidence for cardiac protection?
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, USA
    Int Urol Nephrol 36:617-23. 2004
  2. pmc Emerging clinical role of ranolazine in the management of angina
    David S Vadnais
    Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
    Ther Clin Risk Manag 6:517-30. 2010
  3. ncbi request reprint Recognizing pregnancy-associated cardiovascular risk factors
    Nanette K Wenger
    Emory University School of Medicine, Division of Cardiology, Atlanta, Georgia Emory Heart and Vascular Center, Atlanta, Georgia Electronic address
    Am J Cardiol 113:406-9. 2014
  4. doi request reprint Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association Guidelines
    Nanette K Wenger
    Emory University School of Medicine, Emory Heart and Vascular Center, Atlanta, GA Electronic address
    Adv Chronic Kidney Dis 20:419-22. 2013
  5. doi request reprint Gender disparity in cardiovascular disease: bias or biology?
    Nanette K Wenger
    Department of Medicine Cardiology, Emory University School of Medicine, Consultant, Emory Heart and Vascular Center, Atlanta, GA, USA
    Expert Rev Cardiovasc Ther 10:1401-11. 2012
  6. doi request reprint What's new in antiplatelet and anticoagulant therapy recommendations for unstable angina/non-ST-elevation myocardial infarction: 2012 focused update from the American College of Cardiology Foundation/American Heart Association task force on practice guide
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30303, USA
    Clin Cardiol 35:669-72. 2012
  7. pmc Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists
    Virginia M Miller
    Departments of Surgery, Physiology and Biomedical Engineering, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
    Biol Sex Differ 2:14. 2011
  8. doi request reprint Cardiovascular disease: the female heart is vulnerable: a call to action from the 10Q report
    Nanette K Wenger
    Department of Medicine Cardiology, Emory University School of Medicine, Atlanta, Georgia
    Clin Cardiol 35:134-5. 2012
  9. ncbi request reprint Lipid abnormalities in women: data for risk, data for management
    Nanette K Wenger
    Department of Medicine Cardiology, Emory University School of Medicine, The Department of Cardiology, Grady Memorial Hospital, and the Emory Heart and Vascular Center, Atlanta, Georgia 30303, USA
    Cardiol Rev 14:276-80. 2006
  10. ncbi request reprint Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and other clinical trials?
    Nanette K Wenger
    Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30303, USA
    Cardiol Rev 15:288-90. 2007

Detail Information

Publications97

  1. ncbi request reprint Menopausal hormone therapy: is there evidence for cardiac protection?
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, USA
    Int Urol Nephrol 36:617-23. 2004
    ..The latter Guidelines display the lifestyle and pharmacologic interventions that are appropriate for cardiovascular disease risk reduction for women...
  2. pmc Emerging clinical role of ranolazine in the management of angina
    David S Vadnais
    Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
    Ther Clin Risk Manag 6:517-30. 2010
    ..Ranolazine is a proven antianginal medication in patients with symptomatic coronary heart disease, and should be considered as an initial antianginal agent for those with hypotension or bradycardia...
  3. ncbi request reprint Recognizing pregnancy-associated cardiovascular risk factors
    Nanette K Wenger
    Emory University School of Medicine, Division of Cardiology, Atlanta, Georgia Emory Heart and Vascular Center, Atlanta, Georgia Electronic address
    Am J Cardiol 113:406-9. 2014
    ..There is need for development and validation of a clinometric tool to assess cardiovascular risk and guide management. ..
  4. doi request reprint Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association Guidelines
    Nanette K Wenger
    Emory University School of Medicine, Emory Heart and Vascular Center, Atlanta, GA Electronic address
    Adv Chronic Kidney Dis 20:419-22. 2013
    ....
  5. doi request reprint Gender disparity in cardiovascular disease: bias or biology?
    Nanette K Wenger
    Department of Medicine Cardiology, Emory University School of Medicine, Consultant, Emory Heart and Vascular Center, Atlanta, GA, USA
    Expert Rev Cardiovasc Ther 10:1401-11. 2012
    ....
  6. doi request reprint What's new in antiplatelet and anticoagulant therapy recommendations for unstable angina/non-ST-elevation myocardial infarction: 2012 focused update from the American College of Cardiology Foundation/American Heart Association task force on practice guide
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30303, USA
    Clin Cardiol 35:669-72. 2012
    ..This focused update addresses the use of the newly approved oral antiplatelet agents, prasugrel and ticagrelor, for the management of patients with UA/NSTEMI...
  7. pmc Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists
    Virginia M Miller
    Departments of Surgery, Physiology and Biomedical Engineering, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
    Biol Sex Differ 2:14. 2011
    ..abstract:..
  8. doi request reprint Cardiovascular disease: the female heart is vulnerable: a call to action from the 10Q report
    Nanette K Wenger
    Department of Medicine Cardiology, Emory University School of Medicine, Atlanta, Georgia
    Clin Cardiol 35:134-5. 2012
    ....
  9. ncbi request reprint Lipid abnormalities in women: data for risk, data for management
    Nanette K Wenger
    Department of Medicine Cardiology, Emory University School of Medicine, The Department of Cardiology, Grady Memorial Hospital, and the Emory Heart and Vascular Center, Atlanta, Georgia 30303, USA
    Cardiol Rev 14:276-80. 2006
    ..Application of lipid-lowering therapy with statin drugs is currently underutilized in women, and represents an opportunity to improve clinical cardiovascular outcomes for women...
  10. ncbi request reprint Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and other clinical trials?
    Nanette K Wenger
    Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30303, USA
    Cardiol Rev 15:288-90. 2007
    ....
  11. ncbi request reprint Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study
    N K Wenger
    Emory University School of Medicine, 49 Jesse Hill Jr Drive, SE Atlanta, GA 30303, USA
    Heart 94:434-9. 2008
    ..To examine by secondary analysis of the Treating to New Targets (TNT) study whether the benefits of intensive versus standard levels of lipid lowering are equally applicable to women...
  12. ncbi request reprint Menopausal hormone therapy: currently no evidence for cardiac protection
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine Grady Memorial Hospital Emory Heart and Vascular Center, Atlanta, Georgia, USA
    Pediatr Blood Cancer 44:625-9. 2005
    ....
  13. ncbi request reprint Coronary revascularization in women
    Nanette K Wenger
    Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30303, USA
    Cardiol Rev 13:184-9. 2005
    ..Procedural bleeding complications, among others, warrant pathophysiologic assessment; limitation of such complications can improve clinical outcomes for women...
  14. ncbi request reprint Enrollment and maintenance of elderly patients in cardiovascular clinical trials
    Nanette K Wenger
    Division of Cardiology, Department of Medicine, Emory University School of Medicine, 49 Jessie Hill Jr Drive SE, Atlanta, GA 30303, USA
    Am J Geriatr Cardiol 15:352-6. 2006
    ..Relevant clinical outcomes include improvement in functional independence and quality of life, decrease in costly hospitalizations, and prolongation of meaningful life...
  15. ncbi request reprint You've come a long way, baby: cardiovascular health and disease in women: problems and prospects
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, Grady Memorial Hospital, and Emory Heart and Vascular Center, Atlanta, GA 30303, USA
    Circulation 109:558-60. 2004
  16. ncbi request reprint Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30303, USA
    Ann Intern Med 147:1-9. 2007
    ..Increased life expectancy is associated with an increase in the burden of chronic cardiovascular disease...
  17. ncbi request reprint Coronary heart disease in women: highlights of the past 2 years--stepping stones, milestones and obstructing boulders
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30303, USA
    Nat Clin Pract Cardiovasc Med 3:194-202. 2006
    ..Adherence to recommendations offers the promise of improving the heart health of women. In this article, I summarize new information to guide the preventive, diagnostic and therapeutic management of CHD in women...
  18. ncbi request reprint Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials
    Nanette K Wenger
    Department of Medicine, Emory University School of Medicine, Grady Memorial Hospital, Atlanta, GA, USA
    Am J Cardiol 99:11-8. 2007
    ....
  19. ncbi request reprint Dyslipidemia as a risk factor at elderly age
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, GA 30303, USA
    Am J Geriatr Cardiol 13:4-9. 2004
    ..About one third of elderly men and one half of elderly women have cholesterol levels >240 mg/dL. Remediable dyslipidemia is highly relevant at elderly age and should guide recommendations for cardiovascular disease prevention...
  20. ncbi request reprint [Menopausal hormone therapy and cardiovascular disease]
    Nanette K Wenger
    Emory University School of Medicine, Grady Memorial Hospital, Emory Heart and Vascular Center, Atlanta, Georgia, USA
    Rev Esp Cardiol 59:1058-69. 2006
    ....
  21. ncbi request reprint Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, Georgia, USAGrady Memorial Hospital, Atlanta, Georgia, USAEmory Heart and Vascular Center, Atlanta, Georgia 30303, USA
    Drugs 68:339-58. 2008
    ..This information gap presents a major challenge for future studies, as these subgroups constitute populations of women at high cardiovascular risk...
  22. doi request reprint Current status of cardiac rehabilitation
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, Georgia 30303, USA
    J Am Coll Cardiol 51:1619-31. 2008
    ..The core components of cardiac rehabilitation have been delineated in detail. Implementation of newly available performance measures offers the potential to enhance referral to, enrollment in, and completion of cardiac rehabilitation...
  23. ncbi request reprint HT and CVD prevention. from myth to reality
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, GA 30303, USA
    Fertil Steril 80:10-4; quiz 54-5. 2003
    ..Coronary prevention should involve lifestyle and pharmacologic interventions documented as beneficial in randomized clinical trials and promulgated in national guidelines...
  24. ncbi request reprint Lipid metabolism, physical activity, and postmenopausal hormone therapy
    N K Wenger
    Department of Medicine, Emory University School of Medicine, and Grady Memorial Hospital, Atlanta, GA 30303, USA
    Am J Kidney Dis 32:S80-8. 1998
    ..Goals for coronary risk factor intervention must be developed for patients with specific subsets of chronic renal disease...
  25. ncbi request reprint Coronary heart disease in women: update 2008
    N K Wenger
    Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Pharmacol Ther 83:37-51. 2008
    ..Although these women have more comorbidity and risk factors, other issues including biological differences, treatment differences, and psychosocial factors require management strategies tailored to the unique needs of women...
  26. ncbi request reprint Cardiovascular effects of raloxifene: the potential for cardiovascular protection in women
    N K Wenger
    Emory University School of Medicine, Grady Memorial Hospital, Emory Heart and Vascular Center, Atlanta, GA 30303, USA
    Diabetes Obes Metab 4:166-76. 2002
  27. ncbi request reprint Managing ambulatory anticoagulation
    N K Wenger
    Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303, USA
    J Thromb Thrombolysis 12:31-4. 2001
    ....
  28. doi request reprint Angina in women
    Nanette K Wenger
    Emory University School of Medicine, 49 Jesse Hill Jr Drive, SE, Atlanta, GA 30303, USA
    Curr Cardiol Rep 12:307-14. 2010
    ..Women also have more non-chest pain manifestations of myocardial ischemia than men. These variables must be incorporated in assessments of optimal diagnostic and therapeutic strategies for myocardial ischemia in women...
  29. doi request reprint 2011 ACCF/AHA focused update of the guidelines for the management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 Guideline): highlights for the clinician
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Cardiol 35:3-8. 2012
    ....
  30. ncbi request reprint Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial
    Nanette Kass Wenger
    Emory University, Atlanta, Georgia 30303, USA
    Am J Cardiol 90:1204-10. 2002
    ....
  31. ncbi request reprint Coronary heart disease: the female heart is vulnerable
    Nanette K Wenger
    Emory School of Medicine and Grady Memorial Hospital, Emory Heart and Vascular Center, Atlanta, GA 30303, USA
    Prog Cardiovasc Dis 46:199-229. 2003
    ..Research indicates that behavioral changes on the part of women and reshaping of practice patterns by their health care providers may dramatically reduce the number of women disabled and killed by CHD each year...
  32. doi request reprint What do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women?
    Nanette K Wenger
    Emory University School of Medicine, Emory Heart aned Vascular Center, Atlanta, Georgia 30322, USA
    Clin Cardiol 34:520-3. 2011
    ..Defining a woman's risk status and improving her adherence to preventive lifestyle behaviors and medications is the best strategy to lower the burden of CVD in women...
  33. doi request reprint Menopausal hormone therapy for cardiovascular protection--unfulfilled expectations
    Nanette K Wenger
    Grady Memorial Hospital, Atlanta, GA, USA
    J Cardiovasc Transl Res 2:286-8. 2009
    ..Much remains unknown about the mechanisms of menopausal hormone therapy action and the issue of whether there is a therapeutic window of opportunity for its use...
  34. ncbi request reprint The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans
    W C Hooper
    Hematologic Disease Branch, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Center for Disease Control and Prevention, Atlanta, GA 30333, USA
    Chest 116:880-6. 1999
    ..Because these two genes may interact physiologically, the third objective was to determine if there was a relationship between the polymorphisms with respect to MI and VTE...
  35. doi request reprint Cardiovascular disease prevention tailored for women
    Niels Engberding
    Division of Cardiology, Emory University, School of Medicine, Atlanta, GA 30303, USA
    Expert Rev Cardiovasc Ther 6:1123-34. 2008
    ..Observational data continue to identify discrepancies between women and men, which target areas of need for future research...
  36. ncbi request reprint Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: an ancillary study of volunteers for hers
    P Z Castellano
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA
    J Womens Health Gend Based Med 10:451-61. 2001
    ..Provider behavior was an important factor in influencing women to obtain preventive screening. There were no significant differences in compliance based on provider gender or type of coronary event preceding HERS enrollment...
  37. ncbi request reprint Hypertension and other cardiovascular risk factors in women
    N K Wenger
    Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
    Am J Hypertens 8:94s-99s. 1995
    ..Education is important; unless women consider CHD as part of their illness experience, they are unlikely to heed preventive messages...
  38. ncbi request reprint Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women
    Susmita Mallik
    Department of Medicine, Division of General Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA
    Arch Intern Med 166:876-83. 2006
    ..In the community, younger women are uniquely prone to depression. Whether younger women are also more likely to have depression during hospitalization with AMI is unknown...
  39. ncbi request reprint Menopausal hormone therapy and cardiovascular protection: state of the data 2003
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, Georgia, USA
    J Am Med Womens Assoc 58:236-9. 2003
    ....
  40. ncbi request reprint Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen/progestin combinations, and nonusers
    Liudmila Husak
    Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30306, USA
    Am J Cardiol 93:563-8. 2004
    ..59 to 0.98). Thus, the apparent protective effect of combination menopausal hormone therapy with E+P on CAD is due to differences in other patient characteristics. In contrast, unopposed E therapy may have a protective effect on CAD...
  41. ncbi request reprint Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans
    H Austin
    Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U S Department of Health and Human Services, Atlanta, GA 30333, USA
    J Clin Epidemiol 53:997-1001. 2000
    ..The study also indicated that the HaeIII and the BclI polymorphisms of the beta fibrinogen gene and the MspI polymorphisms of the factor VII gene are not strong determinants of venous thrombosis...
  42. ncbi request reprint Preventing cardiovascular disease in women: an update
    Nanette K Wenger
    Emory University School of Medicine, Grady Memorial Hospital, Emory Heart and Vascular Center, Atlanta, Georgia, USA
    Clin Cardiol 31:109-13. 2008
    ..However, high coronary risk in many women continues to be underrecognized, and women remain undertreated with statins and other therapeutic agents...
  43. pmc Management strategies of dyslipidemia in the elderly: 2005
    Tarek Helmy
    Grady Memorial Hospital, Atlanta, Georgia, USA
    MedGenMed 7:8. 2005
    ..Compelling data noted from recent clinical trials have prompted the NCEP to publish an updated report that addresses the significant interim developments...
  44. ncbi request reprint Time course of depression and outcome of myocardial infarction
    Susmita Parashar
    Divisions of General Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA
    Arch Intern Med 166:2035-43. 2006
    ..Our objective was to evaluate the prognostic importance of transient, new, or persistent depression on outcomes at 6 months after MI...
  45. doi request reprint Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery
    Sanjiv J Shah
    Division of Cardiology, San Francisco General Hospital, University of California, San Francisco, California 94110, USA
    J Am Coll Cardiol 51:1938-43. 2008
    ....
  46. doi request reprint Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study)
    Susmita Parashar
    Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
    Am J Cardiol 103:1120-7. 2009
    ..In conclusion, in older adults with HF, women had significantly better survival than men irrespective of race, suggesting that gender-based survival differences may be more important than race-based differences...
  47. ncbi request reprint Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, GA 30303, USA
    Contemp Clin Trials 26:612-5. 2005
    ..More aggressive cardiovascular risk factor interventions are requisite to achieve optimal target goals for women with documented coronary heart disease...
  48. pmc Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002
    Viola Vaccarino
    Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA
    N Engl J Med 353:671-82. 2005
    ..Although increased attention has been paid to sex and racial differences in the management of myocardial infarction, it is unknown whether these differences have narrowed over time...
  49. ncbi request reprint The Metabolic Syndrome in African Americans: a review
    W Dallas Hall
    African American Lipid and Cardiovascular Council, USA
    Ethn Dis 13:414-28. 2003
    ..This comprehensive review is provided as part of the educational activities of the African-American Lipid and Cardiovascular Council (AALCC)...
  50. ncbi request reprint Clinical characteristics of coronary heart disease in women: emphasis on gender differences
    Nanette K Wenger
    Emory University School of Medicine, Division of Cardiology, Grady Memorial Hospital, 69 Butler Street, S E, Atlanta, GA 30303, USA
    Cardiovasc Res 53:558-67. 2002
  51. pmc Review of the treatment of acute coronary syndrome in elderly patients
    Maan Jokhadar
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA
    Clin Interv Aging 4:435-44. 2009
    ....
  52. ncbi request reprint Cardiovascular disease in the elderly
    N K Wenger
    Department of Medicine Division of Cardiology Emory University School of Medicine, Atlanta, Georgia
    Curr Probl Cardiol 17:609-90. 1992
    ..are indeed formative years, rich in possibilities to unlearn the follies of a lifetime, to see through inbred deceptions, to deepen understanding and compassion, to widen the horizon of honesty, to refine the sense of fairness...
  53. ncbi request reprint Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials
    Mardi Gomberg-Maitland
    Department of Medicine, Section of Cardiology, University of Chicago Hospitals, University of Chicago, 5841 S Maryland Avenue, MC2016, Chicago, IL 60637, USA
    Eur Heart J 27:1947-53. 2006
    ..The risk of stroke is greater among women with atrial fibrillation (AF) than men. Warfarin protects against stroke, but treatment-related bleeding occurs more often in women than in men...
  54. ncbi request reprint Recognition and prevention of cardiovascular disease in women
    Kimberly P Champney
    Emory University School of Medicine, Atlanta, GA, USA
    Compr Ther 31:255-61. 2005
    ..Initiation of menopausal hormone therapy is not recommended for the prevention of coronary heart disease or stroke in women...
  55. ncbi request reprint Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans
    A Dilley
    Hematologic Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E 64, Atlanta, GA 30333, USA
    Thromb Res 103:109-15. 2001
    ..No mutations for G-->A919 (CBS) were detected in the cases or controls. The racial differences of the CBS T-->C833 polymorphism suggest that further investigation into the other areas of the CBS gene is needed...
  56. ncbi request reprint Prehypertension and cardiovascular disease risk in the Women's Health Initiative
    Judith Hsia
    Department of Medicine, George Washington University, 2150 Pennsylvania Ave NW, Washington, DC 20037, USA
    Circulation 115:855-60. 2007
    ..Prehypertension is common and is associated with increased vascular mortality. The extent to which it increases risk of nonfatal myocardial infarction, stroke, and congestive heart failure is less clear...
  57. ncbi request reprint Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans
    W Craig Hooper
    Hematological Disease Branch, Centers for Disease Control and Prevention, MS D02, 1600 Clifton Road, Atlanta, GA 30333, USA
    Am J Hematol 70:1-8. 2002
    ..The data also demonstrated that the allele frequencies of the A1166C variant of the angiotensin II type I receptor were different in African-Americans as compared to Caucasians...
  58. ncbi request reprint Secondary prevention of coronary heart disease in elderly patients
    Ibrahim R Hanna
    Emory University School of Medicine, Atlanta, Georgia 30303, USA
    Am Fam Physician 71:2289-96. 2005
    ..Strategies aimed at these factors have shown variable results and remain ill-defined...
  59. ncbi request reprint Treating dyslipidemia in the elderly
    Khan Pohlel
    Emory University School of Medicine, Atlanta, Georgia 30303, USA
    Curr Opin Lipidol 17:54-7. 2006
    ..This review addresses guidelines of lipid management, discusses data that support their use, and examines the benefits of lipid-lowering therapy in the elderly with attention to the chronic conditions that are common in this population...
  60. ncbi request reprint Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions
    Edgar Argulian
    Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
    Am J Cardiol 98:48-53. 2006
    ..No differences were found in major in-hospital complications by gender...
  61. ncbi request reprint Coronary heart disease in women: battle is won, but the war remains
    P K Mehta
    Department of Cardiology, Emory University School of Medicine, Atlanta, GA 30303, USA
    Minerva Med 98:459-78. 2007
    ....
  62. ncbi request reprint The metabolic syndrome: recognition and management
    W Dallas Hall
    Emory University School of Medicine, Atlanta, GA, USA
    Dis Manag 9:16-33. 2006
    ..Pharmacotherapy is typically needed for control of high blood pressure, hypercoagulability, and increased levels of blood glucose and triglycerides...
  63. ncbi request reprint Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study
    Kiran K Khush
    Division of Cardiology, University of California, San Francisco School of Medicine, San Francisco, Calif, USA
    Circulation 115:576-83. 2007
    ..Statins reduce the rate of major cardiovascular events in high-risk patients, but their potential benefit as treatment for heart failure (HF) is less clear...
  64. ncbi request reprint Coronary heart disease and women: magnitude of the problem
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, Georgia, USA
    Cardiol Rev 10:211-3. 2002
  65. ncbi request reprint Reflections of a "lady doctor"
    Nanette K Wenger
    Division of Cardiology, Emory University School of Medicine, USA
    J Med Assoc Ga 92:13-4. 2003
  66. ncbi request reprint Chronic kidney disease and cognitive impairment in menopausal women
    Manjula Kurella
    Department of Medicine, Divisions of Nephrology, University of California San Francisco, CA 94118 1211, USA
    Am J Kidney Dis 45:66-76. 2005
    ..Although end-stage renal disease has been associated with cognitive impairment, the relation between lesser degrees of chronic kidney disease (CKD) and cognitive impairment is less well understood...
  67. ncbi request reprint Nanette K. Wenger: a woman's life in cardiology
    Joseph S Alpert
    Department of Medicine, University of Arizona Health Sciences Center, Tucson, USA
    Clin Cardiol 27:114-5. 2004
  68. ncbi request reprint Hippocrates, Maimonides, and End-of-Life Issues
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, GA 30303
    Am J Geriatr Cardiol 13:291-2. 2004
  69. ncbi request reprint Guidelines of the Cardiogeriatrics Department of the Brazilian Cardiology Society: commentary by Editorial Board Members of The American Journal of Geriatric Cardiology
    Nanette K Wenger
    Emory University School of Medicine, Atlanta, GA 30303, USA
    Am J Geriatr Cardiol 13:209-16. 2004
  70. ncbi request reprint Chronic kidney disease is a cardiovascular problem--implications for lipid management
    Nanette K Wenger
    Am J Cardiol 94:167-8. 2004
  71. ncbi request reprint Drug therapy in the elderly
    Stephen Scheidt
    Am J Geriatr Cardiol 12:223-4. 2003
  72. ncbi request reprint Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical
    Paul D Thompson
    Circulation 107:3109-16. 2003
  73. ncbi request reprint Review of the International Position Paper on Women's Health and Menopause: a comprehensive approach
    Rodolfo Paoletti
    Department of Pharmacological Sciences, University of Milan, Milan, Italy
    Circulation 107:1336-9. 2003
  74. ncbi request reprint [The current state of hormonal prevention of coronary heart disease in menopausal women]
    Nanette K Wenger
    Rev Esp Cardiol 56:1-8. 2003
    ....
  75. ncbi request reprint Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study
    James Shepherd
    Department of Vascular Biochemistry, University of Glasgow, G31 2ER, UK
    Clin J Am Soc Nephrol 2:1131-9. 2007
    ..This subanalysis of the Treating to New Targets study investigated how intensive lipid lowering with 80 mg of atorvastatin affects renal function when compared with 10 mg in patients with coronary heart disease...
  76. ncbi request reprint Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, a
    Mark A Williams
    Circulation 105:1735-43. 2002
  77. ncbi request reprint Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned
    Curt D Furberg
    Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
    Circulation 105:917-22. 2002
    ..We analyzed the HERS data to determine whether there were specific subgroups of women who responded differently to treatment, either during the first year or in the overall study...
  78. ncbi request reprint Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Coun
    Jennifer H Mieres
    Circulation 111:682-96. 2005
    ....
  79. ncbi request reprint Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    John C LaRosa
    State University of New York Health Science Center, Brooklyn, NY 11203, USA
    N Engl J Med 352:1425-35. 2005
    ..We prospectively assessed the efficacy and safety of lowering LDL cholesterol levels below 100 mg per deciliter (2.6 mmol per liter) in patients with stable coronary heart disease (CHD)...
  80. ncbi request reprint Common cardiac conditions in the elderly are still not well understood
    Michael A Weber
    Am J Geriatr Cardiol 13:237-8. 2004
  81. ncbi request reprint Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
    Elizabeth Barrett-Connor
    Department of Family and Preventive Medicine, University of California, San Diego, La Jolla 92093 0607, USA
    N Engl J Med 355:125-37. 2006
    ..The effect of raloxifene, a selective estrogen-receptor modulator, on coronary heart disease (CHD) and breast cancer is not established...
  82. ncbi request reprint Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement
    Lori Mosca
    Arterioscler Thromb Vasc Biol 24:e29-50. 2004
  83. ncbi request reprint Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology
    Paul D Thompson
    Hartford Hospital, USA
    Circulation 115:2358-68. 2007
    ....
  84. ncbi request reprint Newer diagnostic strategies, application of evidence-based therapies: improving cardiovascular outcomes in an expanding elderly population
    Nanette K Wenger
    Am J Geriatr Cardiol 16:337-8. 2007
  85. ncbi request reprint Denial of standard treatment to the elderly: why?
    Stephen Scheidt
    Am J Geriatr Cardiol 16:5-7. 2007
  86. ncbi request reprint Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?
    David D Waters
    University of California, San Francisco School of Medicine, San Francisco, California 94110, USA
    Am J Cardiol 93:154-8. 2004
    ..9 mmol/L) can provide additional clinical benefit...
  87. ncbi request reprint Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?
    Michael G Shlipak
    General Internal Medicine Section, Veterans Affairs Medical Center, San Francisco, CA 94121, USA
    Am J Kidney Dis 43:37-44. 2004
    ....
  88. ncbi request reprint Evidence-based guidelines for cardiovascular disease prevention in women
    Lori Mosca
    J Am Coll Cardiol 43:900-21. 2004
  89. ncbi request reprint For the patient. What is the Metabolic Syndrome and why is it important?
    W Dallas Hall
    Ethn Dis 13:546. 2003
  90. doi request reprint Sexual satisfaction and cardiovascular disease: the Women's Health Initiative
    Jennifer S McCall-Hosenfeld
    VA Boston Healthcare System, Boston, MA, USA
    Am J Med 121:295-301. 2008
    ..We investigated whether dissatisfaction with sexual activity, a domain of female sexual dysfunction, is associated with prevalent and incident cardiovascular disease in postmenopausal women...
  91. doi request reprint Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study
    James Shepherd
    University of Glasgow, Glasgow, United Kingdom
    J Am Coll Cardiol 51:1448-54. 2008
    ..This subanalysis of the TNT (Treating to New Targets) study investigates the effects of intensive lipid lowering with atorvastatin in patients with coronary heart disease (CHD) with and without pre-existing chronic kidney disease (CKD)...
  92. ncbi request reprint Diet and exercise for perimenopausal women lifestyle interventions can decrease cardiovascular risk
    Nanette K Wenger
    J Am Coll Cardiol 44:586-7. 2004
  93. ncbi request reprint Who should be treated with implantable cardioverter-defibrillators?
    Michael A Weber
    Am J Geriatr Cardiol 15:336-7. 2006
  94. pmc Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk
    Deborah Grady
    University of California, San Francisco, and San Francisco VA Medical Center, San Francisco, CA 94115, USA
    J Natl Cancer Inst 100:854-61. 2008
    ..Here, we provide further details about breast cancer incidence by tumor characteristics, duration of treatment, and subgroup...
  95. ncbi request reprint Atrial fibrillation: many therapeutic options, but great uncertainty about optimal treatment
    Stephen Scheidt
    Am J Geriatr Cardiol 11:350-1. 2002